# Roche Pharma India has launched a new subcutaneous injection version of its immunotherapy drug Tecentriq.

*biotech · news · 2026-05-18 · India Today*

## Key points

- Roche Pharma India launched a seven-minute subcutaneous Tecentriq injection for lung cancer patients.
- The new injection targets non-small cell lung cancer with high PD-L1 expression, benefiting nearly half of NSCLC cases.
- Each dose costs Rs 3.7 lakh, with multiple cycles driving up total treatment expenses significantly.
- Tecentriq is now included in the Central Government Health Scheme and Roche's Blue Tree patient support programme.

**Companies:** Roche Pharma India
**Countries:** India

[Read the full story on India Today](https://www.indiatoday.in/health/story/7-minute-cancer-injection-now-in-india-know-its-cost-and-where-to-get-it-2913299-2026-05-18)

---

Canonical: https://newsio.io/n/007a044b-d142-489e-920c-7cc4fb7a6de5/roche-pharma-india-has-launched-a-new-subcutaneous-injection-version-of-its-immu
Summarized by Newsio from India Today. https://newsio.io/how-it-works